Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-16-142260

Chief Operating Officer sold 714 shares at $2.89 ($2,063)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Keuer Thomas A Chief Operating Officer 2016-09-20 Sale −714 $2.89 $2,063 15,383 D
Open-market sales · 714 sh · avg $2.89 · $2,063
Loading xslF345X03/doc4.xml…